Leukemia Research
Volume 34, Issue 1 , Pages 6-17 , January 2010

Incorporating novel agents in the treatment of myelodysplastic syndromes

  • Konstantinos Anargyrou

      Affiliations

    • Department of Hematology, 251 General Air Force Hospital, Athens, Greece
    • ,
  • Theodoros P. Vassilakopoulos

      Affiliations

    • Department of Hematology, National and Kapodistrian University School of Medicine, Laikon General Hospital, Athens, Greece
    • ,
  • Maria K. Angelopoulou

      Affiliations

    • Department of Hematology, National and Kapodistrian University School of Medicine, Laikon General Hospital, Athens, Greece
    • ,
  • Evangelos Terpos

      Affiliations

    • Department of Clinical Therapeutics, University of Athens School of Medicine, Alexandra General Hospital, Athens, Greece
    • Corresponding Author InformationCorresponding author. Tel.: +30 210 7463803; fax: +30 210 7464676.
    • Department of Clinical Therapeutics, University of Athens School of Medicine, Alexandra General Hospital, 5 Marathonomahon street, Drosia 145-72, Athens, Greece.

Received 23 May 2009 ,Revised 11 July 2009 ,Accepted 13 July 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(09)00366-X

doi: 10.1016/j.leukres.2009.07.021

Leukemia Research
Volume 34, Issue 1 , Pages 6-17 , January 2010

Article Tools

* Image Usage & Resolution